Biotechnology stocks
Every US Biotechnology company with filed annual reports: 549, in the Healthcare sector, with the ratios the screener prints. A name opens the company’s page, where every filed figure carries the filing it was read from and every price the day of its close.
Medians across Biotechnology companies
- Price to earnings
- 17.08x of 48
- Price to book
- 2.73x of 356
- Enterprise value to EBIT
- 25.39x of 23
- Free cash flow yield
- -13.2% of 303
- Return on invested capital, after tax
- -58.5% of 72
- Debt to equity
- 0.10 of 214
- Dividend yield
- 0.2% of 4
The companies
| Company | Market cap | P/E | P/B | EV/EBIT | FCF yld | ROIC | D/E | Div yld |
|---|---|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated VRTX | 128.90B | 32.91x | 7.03x | n/a | 2.4% | n/a | n/a | n/a |
| Moderna, Inc. MRNA | 94.42B | n/m | 10.64x | n/a | -2.2% | n/a | 0.15 | n/a |
| Regeneron Pharmaceuticals, Inc. REGN | 81.99B | 18.49x | 2.77x | n/a | 4.7% | n/a | n/a | 0.5% |
| argenx SE ARGX | 53.22B | 41.19x | 7.27x | 47.23x | 1.3% | n/a | 0.01 | n/a |
| Revolution Medicines, Inc. RVMD | 40.57B | n/m | 22.06x | n/a | -2.5% | n/a | n/a | n/a |
| Alnylam Pharmaceuticals, Inc. ALNY | 31.32B | 97.92x | 39.94x | n/a | 1.5% | n/a | n/a | n/a |
| Royalty Pharma plc RPRX | 26.55B | 33.31x | 5.20x | 26.93x | n/a | 10.5% | 1.38 | n/a |
| Roivant Sciences Ltd. ROIV | 24.59B | n/m | 5.22x | n/a | -3.2% | n/a | n/a | n/a |
| Genmab A/S GMAB | 23.26B | 24.15x | 3.98x | 25.32x | 4.9% | 8.9% | 0.93 | n/a |
| United Therapeutics Corporation UTHR | 23.23B | 17.97x | 3.66x | 16.34x | 4.0% | 21.0% | n/a | n/a |
| Incyte Corporation INCY | 22.96B | 17.19x | 4.40x | n/a | n/a | n/a | n/a | n/a |
| BioNTech SE BNTX | 22.62B | n/m | 1.05x | n/a | 1.4% | n/a | n/a | n/a |
| Insmed Incorporated INSM | 21.67B | n/m | 26.72x | n/a | -4.9% | n/a | n/a | n/a |
| Exelixis, Inc. EXEL | 15.79B | 21.82x | 8.19x | n/a | 5.0% | n/a | n/a | n/a |
| Ascendis Pharma A/S ASND | 14.14B | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| Jazz Pharmaceuticals plc JAZZ | 13.92B | n/m | 3.03x | n/a | 9.9% | -2.9% | 1.26 | n/a |
| Halozyme Therapeutics, Inc. HALO | 13.79B | 46.03x | 308.43x | 36.46x | 4.3% | 15.2% | 44.60 | n/a |
| BridgeBio Pharma, Inc. BBIO | 13.14B | n/m | n/m | n/a | -3.5% | n/a | n/m | n/a |
| Corcept Therapeutics Incorporated CORT | 12.26B | 119.34x | 21.00x | n/a | 1.0% | n/a | n/a | n/a |
| Summit Therapeutics Inc. SMMT | 12.26B | n/m | 17.44x | n/a | -2.8% | -237.5% | 0.03 | n/a |
| Bio-Techne Corporation TECH | 11.37B | 61.98x | 5.40x | 45.30x | 2.3% | 8.9% | 0.14 | 0.4% |
| BioMarin Pharmaceutical Inc. BMRN | 10.85B | 30.80x | 1.82x | 25.39x | 6.5% | 5.5% | 0.11 | n/a |
| Madrigal Pharmaceuticals, Inc. MDGL | 10.62B | n/m | 21.67x | n/a | -1.4% | n/a | 0.58 | n/a |
| ImmunityBio, Inc. IBRX | 10.60B | n/m | n/m | n/a | -3.4% | n/a | n/m | n/a |
| Vaxcyte, Inc. PCVX | 10.01B | n/m | 3.31x | n/a | -7.5% | n/a | n/a | n/a |
| Krystal Biotech, Inc. KRYS | 9.77B | 46.61x | 8.10x | n/a | 1.9% | n/a | n/a | n/a |
| Caris Life Sciences, Inc. CAI | 8.98B | n/m | 15.55x | 190.85x | 0.8% | 21.6% | 0.74 | n/a |
| Kymera Therapeutics, Inc. KYMR | 8.89B | n/m | 5.78x | n/a | -2.6% | -26.8% | 0.05 | n/a |
| Cytokinetics, Incorporated CYTK | 8.89B | n/m | n/m | n/a | -6.0% | n/m | n/m | n/a |
| Protagonist Therapeutics, Inc. PTGX | 8.84B | n/m | 14.12x | n/a | 0.7% | n/a | n/a | n/a |
| TG Therapeutics, Inc. TGTX | 8.57B | 18.06x | 13.95x | n/a | -0.3% | n/a | n/a | n/a |
| Axsome Therapeutics, Inc. AXSM | 8.47B | n/m | 91.16x | n/a | -1.2% | n/m | 2.47 | n/a |
| Arrowhead Pharmaceuticals, Inc. ARWR | 8.26B | n/m | 16.79x | n/a | 2.0% | n/a | n/a | n/a |
| Spyre Therapeutics, Inc. SYRE | 7.39B | n/m | 10.34x | n/a | n/a | n/a | n/a | n/a |
| Ionis Pharmaceuticals, Inc. IONS | 7.33B | n/m | 14.43x | n/a | -4.5% | n/a | 4.15 | n/a |
| Praxis Precision Medicines, Inc. PRAX | 6.93B | n/m | 6.36x | n/a | -4.5% | n/a | 0.0001 | n/a |
| Abivax S.A. ABVX | 6.78B | n/m | 13.29x | n/a | -2.7% | n/a | n/a | n/a |
| Alkermes plc ALKS | 6.73B | 27.28x | 3.72x | 25.39x | 7.1% | 14.0% | 0.04 | n/a |
| Iovance Biotherapeutics, Inc. IOVA | 6.67B | n/m | 9.54x | n/a | -5.0% | -68.6% | 0.07 | n/a |
| Kiniksa Pharmaceuticals, Ltd. KNSA | 6.24B | 99.92x | 11.12x | n/a | 2.2% | n/a | n/a | n/a |
| Belite Bio, Inc BLTE | 6.07B | n/m | 7.88x | n/a | -0.6% | -20.1% | 0.0006 | n/a |
| Rhythm Pharmaceuticals, Inc. RYTM | 6.06B | n/m | 41.11x | n/a | -2.0% | n/a | 0.81 | n/a |
| Ligand Pharmaceuticals Incorporated LGND | 5.95B | 46.35x | 5.96x | n/a | 0.8% | n/a | n/a | n/a |
| Immunovant, Inc. IMVT | 5.68B | n/m | 5.89x | n/a | -8.1% | n/a | 0.00008 | n/a |
| Kodiak Sciences Inc. KOD | 5.54B | n/m | 29.79x | n/a | -2.9% | n/a | n/a | n/a |
| CG Oncology, Inc. Common stock CGON | 5.48B | n/m | 6.35x | n/a | -2.8% | n/a | 0.01 | n/a |
| Mirum Pharmaceuticals, Inc. MIRM | 5.35B | n/m | 13.14x | n/a | 1.3% | n/a | 1.02 | n/a |
| Erasca, Inc. ERAS | 5.20B | n/m | 12.97x | n/a | -2.3% | -47.2% | 0.14 | n/a |
| Cogent Biosciences, Inc. COGT | 5.12B | n/m | 5.98x | n/a | -7.0% | n/a | n/a | n/a |
| PTC Therapeutics, Inc. PTCT | 5.09B | 7.11x | n/m | n/a | 13.0% | n/a | n/m | n/a |
| CRISPR Therapeutics AG CRSP | 4.98B | n/m | 2.41x | n/a | -7.5% | n/a | 0.11 | n/a |
| Travere Therapeutics, Inc. TVTX | 4.98B | n/m | 41.01x | n/a | n/a | n/a | 2.86 | n/a |
| Scholar Rock Holding Corporation SRRK | 4.95B | n/m | 18.99x | n/a | -6.5% | n/a | 0.44 | n/a |
| Oruka Therapeutics, Inc. ORKA | 4.89B | n/m | 10.36x | n/a | -1.8% | n/a | n/a | n/a |
| Definium Therapeutics, Inc. DFTX | 4.60B | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Dianthus Therapeutics, Inc. DNTH | 4.17B | n/m | 5.83x | n/a | -4.5% | n/a | 0.003 | n/a |
| Edgewise Therapeutics, Inc. EWTX | 4.11B | n/m | 7.53x | n/a | -3.7% | n/a | 0.01 | n/a |
| AbCellera Biologics Inc. ABCL | 4.11B | n/m | 3.92x | n/a | -4.6% | n/a | n/a | n/a |
| Adaptive Biotechnologies Corporation ADPT | 4.08B | n/m | 17.74x | n/a | -1.3% | -15.9% | 0.96 | n/a |
| Tango Therapeutics, Inc. TNGX | 3.83B | n/m | 7.62x | n/a | -5.3% | n/a | n/a | n/a |
| Relay Therapeutics, Inc. RLAY | 3.79B | n/m | 5.23x | n/a | -8.0% | n/a | 0.06 | n/a |
| Legend Biotech Corporation LEGN | 3.66B | n/m | 3.65x | n/a | -3.5% | n/a | 0.41 | n/a |
| Arcutis Biotherapeutics, Inc. ARQT | 3.66B | n/m | 19.54x | n/a | -0.2% | n/a | 0.60 | n/a |
| Telix Pharmaceuticals Limited TLX | 3.59B | n/m | 8.65x | 131.54x | -1.2% | n/a | 1.12 | n/a |
| Veracyte, Inc. VCYT | 3.57B | 52.85x | 2.73x | 56.32x | 3.5% | 5.7% | 0.03 | n/a |
| Viking Therapeutics, Inc. VKTX | 3.48B | n/m | 4.83x | n/a | n/a | n/a | 0.0002 | n/a |
| Amylyx Pharmaceuticals, Inc. AMLX | 3.47B | n/m | 8.57x | n/a | -4.7% | n/a | 0.02 | n/a |
| ACADIA Pharmaceuticals Inc. ACAD | 3.39B | 8.50x | 2.73x | n/a | 3.1% | n/a | n/a | n/a |
| Xenon Pharmaceuticals Inc. XENE | 3.33B | n/m | 4.68x | n/a | -10.3% | n/a | n/a | n/a |
| Tarsus Pharmaceuticals, Inc. TARS | 3.32B | n/m | 8.64x | n/a | -0.8% | n/a | n/a | n/a |
| IDEAYA Biosciences, Inc. IDYA | 3.27B | n/m | 2.93x | n/a | -2.5% | n/a | 0.03 | n/a |
| Liquidia Corporation LQDA | 3.11B | n/m | 66.89x | n/a | -1.3% | n/a | n/a | n/a |
| Celcuity Inc. CELC | 2.95B | n/m | 28.04x | n/a | -5.5% | n/a | n/a | n/a |
| Denali Therapeutics Inc. DNLI | 2.93B | n/m | 3.12x | n/a | -13.3% | n/a | 0.04 | n/a |
| Enliven Therapeutics, Inc. ELVN | 2.88B | n/m | 4.85x | n/a | -3.2% | n/a | n/a | n/a |
| Arcus Biosciences, Inc. RCUS | 2.87B | n/m | 3.88x | n/a | -19.8% | n/a | n/a | n/a |
| Dyne Therapeutics, Inc. DYN | 2.85B | n/m | 2.02x | n/a | -20.6% | n/a | 0.17 | n/a |
| Zai Lab Limited ZLAB | 2.64B | n/m | n/a | n/a | n/a | -86.7% | 0.31 | n/a |
| Nurix Therapeutics, Inc. NRIX | 2.59B | n/m | 4.01x | n/a | -12.2% | n/a | n/a | n/a |
| Precigen, Inc. PGEN | 2.58B | n/m | 107.69x | n/a | -4.0% | n/a | n/a | n/a |
| Beam Therapeutics Inc. BEAM | 2.55B | n/m | 1.98x | n/a | -14.7% | n/a | n/a | n/a |
| MBX Biosciences, Inc. Common Stock MBX | 2.44B | n/m | 5.01x | n/a | -4.4% | -33.3% | 0.002 | n/a |
| NewAmsterdam Pharma Company N.V. NAMS | 2.41B | n/m | 3.57x | n/a | -6.1% | n/a | n/a | n/a |
| ADMA Biologics, Inc. ADMA | 2.41B | 17.31x | 5.51x | 13.69x | 1.1% | 32.8% | 0.17 | n/a |
| SELLAS Life Sciences Group, Inc. SLS | 2.29B | n/m | n/a | n/a | n/a | n/a | 0.01 | n/a |
| Celldex Therapeutics, Inc. CLDX | 2.27B | n/m | 3.65x | n/a | -11.1% | -57.4% | 0.004 | n/a |
| Harmony Biosciences Holdings, Inc. HRMY | 2.23B | 13.87x | 2.57x | 7.95x | 15.5% | 53.6% | 0.19 | n/a |
| Recursion Pharmaceuticals, Inc. RXRX | 2.23B | n/m | 1.65x | n/a | -20.3% | -133.9% | 0.09 | n/a |
| Aurinia Pharmaceuticals Inc. AUPH | 2.23B | 7.82x | 3.99x | 22.07x | n/a | n/a | 0.13 | n/a |
| Viridian Therapeutics, Inc. VRDN | 2.22B | n/m | 3.07x | n/a | -12.5% | n/a | n/a | n/a |
| Disc Medicine, Inc. IRON | 2.17B | n/m | 2.70x | n/a | -9.1% | n/a | n/a | n/a |
| Fortrea Holdings Inc. FTRE | 2.16B | n/m | 3.84x | n/a | 4.1% | n/a | 1.98 | n/a |
| Novavax, Inc. NVAX | 2.12B | 4.71x | n/m | n/a | -11.3% | n/a | n/m | n/a |
| Vericel Corporation VCEL | 2.10B | 124.30x | 6.03x | 193.41x | 1.2% | 3.0% | 0.27 | n/a |
| Pharvaris N.V. PHVS | 2.07B | n/m | 6.81x | n/a | -7.4% | n/a | n/a | n/a |
| Vera Therapeutics, Inc. VERA | 2.06B | n/m | 3.04x | n/a | -13.2% | n/a | 0.13 | n/a |
| Immunome, Inc. IMNM | 2.05B | n/m | 2.40x | n/a | -13.2% | n/a | n/a | n/a |
| BioCryst Pharmaceuticals, Inc. BCRX | 2.05B | 6.37x | n/m | n/a | 19.7% | n/a | n/m | n/a |
| Maravai LifeSciences Holdings, Inc. MRVI | 2.00B | n/m | n/a | n/a | n/a | -58.7% | 1.72 | n/a |
| Agios Pharmaceuticals, Inc. AGIO | 1.93B | n/m | 1.57x | n/a | -20.1% | -41.2% | 0.03 | n/a |
| Mineralys Therapeutics, Inc. MLYS | 1.91B | n/m | 2.26x | n/a | -9.7% | n/a | n/a | n/a |
| Sarepta Therapeutics, Inc. SRPT | 1.88B | n/m | 1.56x | n/a | -17.3% | n/a | 0.91 | n/a |
| Zymeworks Inc. ZYME | 1.85B | n/m | 7.23x | n/a | -1.8% | n/a | 0.07 | n/a |
| Xeris Biopharma Holdings, Inc. XERS | 1.84B | n/m | 127.07x | 75.78x | n/a | 15.5% | 18.85 | n/a |
| Palvella Therapeutics, Inc. PVLA | 1.83B | n/m | 51.20x | n/a | n/a | n/a | n/a | n/a |
| Mesoblast Limited MESO | 1.81B | n/m | 3.03x | n/a | -2.8% | n/a | n/a | n/a |
| UroGen Pharma Ltd. URGN | 1.79B | n/m | n/m | n/a | -9.2% | n/a | n/m | n/a |
| Xencor, Inc. XNCR | 1.78B | n/m | 2.80x | n/a | -7.8% | n/a | 0.30 | n/a |
| Vir Biotechnology, Inc. VIR | 1.77B | n/m | 1.90x | n/a | -27.4% | n/a | n/a | n/a |
| Septerna, Inc. SEPN | 1.75B | n/m | 4.34x | n/a | 6.6% | n/a | 0.06 | n/a |
| Biohaven Ltd. BHVN | 1.73B | n/m | 23.62x | n/a | -49.6% | n/a | 5.47 | n/a |
| Trevi Therapeutics, Inc. TRVI | 1.73B | n/m | 8.91x | n/a | -2.6% | -29.8% | 0.004 | n/a |
| Nuvation Bio Inc. NUVB | 1.66B | n/m | 5.44x | n/a | -10.9% | -107.1% | 0.19 | n/a |
| Zenas BioPharma, Inc. ZBIO | 1.66B | n/m | 4.69x | n/a | -15.2% | -181.1% | 0.33 | n/a |
| Ocular Therapeutix, Inc. OCUL | 1.62B | n/m | 2.11x | n/a | -15.7% | n/m | 0.12 | n/a |
| Intellia Therapeutics, Inc. NTLA | 1.59B | n/m | 1.83x | n/a | -32.2% | n/a | 0.14 | n/a |
| Stoke Therapeutics, Inc. STOK | 1.59B | n/m | 4.13x | n/a | 3.1% | n/a | n/a | n/a |
| uniQure N.V. QURE | 1.56B | n/m | 6.51x | n/a | -13.8% | n/a | n/a | n/a |
| Absci Corporation ABSI | 1.52B | n/m | 6.41x | n/a | -7.7% | n/a | n/a | n/a |
| Innoviva, Inc. INVA | 1.51B | 5.19x | 1.51x | 9.08x | 11.1% | 15.2% | 0.23 | n/a |
| Ultragenyx Pharmaceutical Inc. RARE | 1.50B | n/m | n/m | n/a | -31.6% | n/a | n/m | n/a |
| Immunocore Holdings plc IMCR | 1.49B | n/m | 3.90x | n/a | -1.0% | n/a | 1.15 | n/a |
| Eton Pharmaceuticals, Inc. ETON | 1.47B | n/m | 52.81x | n/a | 0.7% | n/a | 1.19 | n/a |
| AnaptysBio, Inc. ANAB | 1.46B | n/m | 39.58x | n/a | 1.3% | n/a | n/a | n/a |
| Rapport Therapeutics, Inc. Common Stock RAPP | 1.42B | n/m | 2.38x | n/a | -7.7% | n/a | 0.02 | n/a |
| ASCENTAGE PHARMA GROUP INTERNATIONAL AAPG | 1.37B | n/m | n/a | n/a | -1.5% | n/a | n/a | n/a |
| Omeros Corporation OMER | 1.36B | n/m | n/m | n/a | -9.7% | n/a | n/m | n/a |
| Inhibrx Biosciences, Inc. INBX | 1.33B | n/m | 175.35x | n/a | -9.3% | n/m | 13.39 | n/a |
| ORIC Pharmaceuticals, Inc. ORIC | 1.32B | n/m | 2.92x | n/a | -10.0% | n/a | 0.02 | n/a |
| GH Research PLC GHRS | 1.29B | n/m | 4.62x | n/a | -3.4% | -178.8% | 0.002 | n/a |
| Structure Therapeutics Inc. GPCR | 1.28B | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Syndax Pharmaceuticals, Inc. SNDX | 1.22B | n/m | 18.30x | n/a | -27.3% | n/a | n/a | n/a |
| Alpha Tau Medical Ltd. DRTS | 1.22B | n/m | 15.79x | n/a | -2.7% | n/a | n/a | n/a |
| Taysha Gene Therapies, Inc. TSHA | 1.21B | n/m | 4.83x | n/a | -7.9% | n/a | n/a | n/a |
| Bicara Therapeutics Inc. Common Stock BCAX | 1.17B | n/m | 2.90x | n/a | -9.2% | n/a | n/a | n/a |
| Tyra Biosciences, Inc. TYRA | 1.14B | n/m | 4.38x | n/a | -8.4% | n/a | 0.02 | n/a |
| Nanobiotix S.A. NBTX | 1.13B | n/m | n/m | n/a | -3.4% | n/a | n/m | n/a |
| Replimune Group, Inc. REPL | 1.11B | n/m | 6.56x | n/a | -26.1% | -464.7% | 0.67 | n/a |
| Nektar Therapeutics NKTR | 1.08B | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Immatics N.V. IMTX | 1.07B | n/m | 1.97x | n/a | -19.2% | n/a | n/a | n/a |
| Janux Therapeutics, Inc. JANX | 1.06B | n/m | 1.12x | n/a | -7.8% | n/a | 0.02 | n/a |
| Vor Biopharma Inc. VOR | 1.05B | n/m | n/m | n/a | n/a | n/a | n/m | 0.0% |
| MannKind Corporation MNKD | 1.03B | 159.50x | n/m | n/a | 1.4% | n/a | n/m | n/a |
| Savara Inc. SVRA | 973.9M | n/m | 5.19x | n/a | -9.6% | -61.8% | 0.15 | n/a |
| MeiraGTx Holdings plc MGTX | 949.9M | n/m | n/m | n/a | -6.3% | n/a | n/m | n/a |
| Alto Neuroscience, Inc. ANRO | 887.7M | n/m | 4.32x | n/a | -7.9% | n/m | 0.14 | n/a |
| Rigel Pharmaceuticals, Inc. RIGL | 882.6M | 2.32x | 2.27x | n/a | n/a | n/a | n/a | n/a |
| Jade Biosciences, Inc. JBIO | 875.1M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| MoonLake Immunotherapeutics MLTX | 873.2M | n/m | 2.17x | n/a | -29.6% | n/a | n/a | n/a |
| Monte Rosa Therapeutics, Inc. GLUE | 863.4M | n/m | 3.61x | n/a | -3.3% | n/a | n/a | 0.0% |
| Kura Oncology, Inc. KURA | 862.9M | n/m | 4.88x | n/a | -8.3% | n/a | 0.12 | n/a |
| Arbutus Biopharma Corporation ABUS | 849.9M | n/m | 10.73x | n/a | -4.8% | n/a | 0.01 | n/a |
| Verastem, Inc. VSTM | 835.9M | n/m | 11.18x | n/a | n/a | n/a | n/a | n/a |
| Corvus Pharmaceuticals, Inc. CRVS | 828.6M | n/m | 13.54x | n/a | -4.0% | -74.7% | 0.02 | n/a |
| ArriVent BioPharma, Inc. Common Stock AVBP | 827.9M | n/m | 2.10x | n/a | n/a | n/a | 0.00005 | n/a |
| Alumis Inc. Common Stock ALMS | 816.7M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Ardelyx, Inc. ARDX | 813.6M | n/m | 4.72x | n/a | -5.6% | n/a | n/a | n/a |
| Ginkgo Bioworks Holdings, Inc. DNA | 791.9M | n/m | 1.28x | n/a | -27.4% | n/a | n/a | n/a |
| Geron Corporation GERN | 790.2M | n/m | 3.63x | n/a | n/a | n/a | n/a | n/a |
| Sana Biotechnology, Inc. SANA | 740.9M | n/m | 3.90x | n/a | -23.1% | n/a | n/a | n/a |
| Lexicon Pharmaceuticals, Inc. LXRX | 734.2M | n/m | 5.57x | n/a | -11.3% | n/a | 0.58 | n/a |
| Immix Biopharma, Inc. IMMX | 719.6M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Achieve Life Sciences, Inc. ACHV | 716.7M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| 4D Molecular Therapeutics, Inc. FDMT | 711.0M | n/m | 1.47x | n/a | -14.7% | n/a | 0.04 | n/a |
| OmniAb, Inc. OABI | 687.7M | n/m | 2.01x | n/a | -6.9% | -25.7% | 0.08 | n/a |
| Cybin Inc. Common Stock HELP | 684.9M | n/m | 4.10x | n/a | n/a | n/a | n/a | n/a |
| MiMedx Group, Inc. MDXG | 682.2M | 14.18x | 2.73x | 8.72x | 10.4% | 41.5% | 0.09 | n/a |
| Candel Therapeutics, Inc. CADL | 681.8M | n/m | 9.09x | n/a | -8.2% | n/a | n/a | n/a |
| Pharming Group N.V. PHAR | 681.6M | 239.07x | n/a | n/a | 7.9% | n/a | n/a | n/a |
| Gyre Therapeutics, Inc. GYRE | 678.6M | 106.67x | 10.86x | n/a | -0.03% | n/a | n/a | n/a |
| Aura Biosciences, Inc. AURA | 657.5M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Design Therapeutics, Inc. DSGN | 655.9M | n/m | 2.83x | n/a | -9.1% | n/a | 0.01 | n/a |
| Prime Medicine, Inc. PRME | 654.8M | n/m | 4.44x | n/a | -31.1% | n/a | n/a | n/a |
| Avalo Therapeutics, Inc. AVTX | 644.1M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Adlai Nortye Ltd. ANL | 641.7M | n/m | 25.18x | n/a | -8.1% | n/m | 1.07 | n/a |
| Wave Life Sciences Ltd. WVE | 628.6M | n/m | 1.04x | n/a | -35.0% | n/a | n/a | n/a |
| Climb Bio, Inc. CLYM | 626.6M | n/m | 4.61x | n/a | -7.4% | n/a | 0.003 | n/a |
| Nuvectis Pharma, Inc. NVCT | 618.0M | n/m | 22.43x | n/a | n/a | n/m | n/a | n/a |
| Solid Biosciences Inc. SLDB | 615.5M | n/m | 2.79x | n/a | -31.4% | -126.8% | 0.12 | n/a |
| Zevra Therapeutics, Inc. ZVRA | 609.9M | 7.34x | 3.80x | n/a | -0.4% | n/a | n/a | n/a |
| Phathom Pharmaceuticals, Inc. PHAT | 606.8M | n/m | n/m | n/a | -30.5% | n/m | n/m | n/a |
| Olema Pharmaceuticals, Inc. OLMA | 601.1M | n/m | 1.25x | n/a | n/a | n/a | 0.01 | n/a |
| Annexon, Inc. ANNX | 589.8M | n/m | 2.64x | n/a | -33.4% | n/a | n/a | n/a |
| CorMedix Inc. CRMD | 581.5M | 3.32x | 1.43x | n/a | 29.7% | n/a | n/a | n/a |
| Valneva SE VALN | 560.4M | n/m | 4.71x | n/a | -11.5% | n/a | 1.95 | n/a |
| Shattuck Labs, Inc. STTK | 555.0M | n/m | 4.67x | n/a | -10.4% | n/a | n/a | n/a |
| Puma Biotechnology, Inc. PBYI | 543.0M | 16.97x | 4.09x | 14.26x | 7.8% | 25.1% | 0.22 | n/a |
| Bright Minds Biosciences Inc. DRUG | 534.7M | n/m | 137.07x | n/a | n/a | n/a | 0.02 | n/a |
| CytomX Therapeutics, Inc. CTMX | 525.1M | n/m | n/a | n/a | n/a | n/a | 0.04 | n/a |
| ProKidney Corp. PROK | 489.2M | n/m | n/m | n/a | -27.7% | n/m | n/m | n/a |
| Monopar Therapeutics Inc. MNPR | 481.9M | n/m | 3.86x | n/a | n/a | n/a | 0.002 | n/a |
| Entera Bio Ltd. ENTX | 481.5M | n/a | n/a | n/a | n/a | -177.8% | 0.04 | n/a |
| YD Bio Limited Ordinary Shares YDES | 477.4M | n/m | n/m | n/a | -1.7% | n/a | n/m | n/a |
| REGENXBIO Inc. RGNX | 472.7M | n/m | 3.59x | n/a | -34.2% | n/a | n/a | n/a |
| Crescent Biopharma, Inc. CBIO | 463.6M | n/m | 2.28x | n/a | -15.6% | n/a | n/a | n/a |
| Allogene Therapeutics, Inc. ALLO | 463.0M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Arvinas, Inc. ARVN | 462.0M | n/m | 1.17x | n/a | -54.3% | n/a | 0.02 | n/a |
| Altimmune, Inc. ALT | 459.1M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Autolus Therapeutics plc AUTL | 457.8M | n/m | 2.57x | n/a | -66.1% | n/a | n/a | n/a |
| Oculis Holding AG OCS | 455.8M | n/m | 1.92x | n/a | -17.7% | n/a | n/a | n/a |
| Silence Therapeutics plc SLN | 441.6M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Ovid Therapeutics Inc. OVID | 441.4M | n/m | 3.38x | n/a | -8.7% | -32.4% | 0.10 | n/a |
| Prothena Corporation plc PRTA | 436.4M | n/m | 1.63x | n/a | -35.8% | n/a | n/a | n/a |
| DiaMedica Therapeutics Inc. DMAC | 433.6M | n/m | 6.73x | n/a | -7.7% | n/a | 0.004 | n/a |
| Capricor Therapeutics, Inc. CAPR | 421.0M | n/m | 1.10x | n/a | -21.5% | n/a | n/a | n/a |
| Assembly Biosciences, Inc. ASMB | 418.8M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Tectonic Therapeutic, Inc. TECX | 416.4M | n/m | 1.55x | n/a | -15.4% | n/m | 0.01 | n/a |
| Zura Bio Limited ZURA | 410.1M | n/m | 3.97x | n/a | -16.1% | n/a | n/a | n/a |
| ARS Pharmaceuticals, Inc. SPRY | 404.8M | n/m | 3.51x | n/a | -42.7% | n/a | n/a | n/a |
| Neurogene Inc. NGNE | 378.5M | n/m | 1.93x | n/a | -15.3% | n/a | n/a | n/a |
| Rezolute, Inc. RZLT | 377.2M | n/m | 4.02x | n/a | n/a | n/a | n/a | n/a |
| Editas Medicine, Inc. EDIT | 374.7M | n/m | n/a | n/a | n/a | n/m | 2.81 | n/a |
| Kyverna Therapeutics, Inc. KYTX | 369.2M | n/m | 1.14x | n/a | -58.2% | n/a | n/a | n/a |
| Atea Pharmaceuticals, Inc. AVIR | 363.3M | n/m | 1.34x | n/a | n/a | -96.4% | 0.003 | n/a |
| Fennec Pharmaceuticals Inc. FENC | 362.9M | n/m | 8.34x | n/a | n/a | n/m | n/a | n/a |
| Orchestra BioMed Holdings, Inc. OBIO | 345.0M | n/m | 5.12x | n/a | -18.0% | n/a | 0.31 | n/a |
| C4 Therapeutics, Inc. CCCC | 342.0M | n/m | 0.90x | n/a | -43.1% | n/a | n/a | n/a |
| Relmada Therapeutics, Inc. RLMD | 341.3M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Opus Genetics, Inc. IRD | 336.9M | n/m | 16.42x | n/a | n/a | n/m | 0.07 | n/a |
| Enanta Pharmaceuticals, Inc. ENTA | 334.1M | n/m | 5.16x | n/a | -9.6% | n/a | n/a | n/a |
| Cypherpunk Technologies Inc. CYPH | 325.4M | n/a | n/a | n/a | n/a | -14.1% | 0.0003 | n/a |
| Indaptus Therapeutics, Inc. INDP | 322.7M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Arcturus Therapeutics Holdings Inc. ARCT | 320.3M | n/m | 1.44x | n/a | -24.1% | n/a | 0.12 | n/a |
| Agenus Inc. AGEN | 301.7M | n/m | n/m | n/a | n/a | n/m | n/m | n/a |
| Contineum Therapeutics, Inc. Class A Common Stock CTNM | 297.2M | n/m | 0.84x | n/a | -25.4% | -35.1% | 0.03 | n/a |
| Artiva Biotherapeutics, Inc. ARTV | 296.3M | n/m | n/a | n/a | n/a | n/a | 0.10 | n/a |
| Benitec Biopharma Inc. BNTC | 295.1M | n/m | 2.23x | n/a | -4.2% | n/a | n/a | n/a |
| Fulcrum Therapeutics, Inc. FULC | 280.0M | n/m | 0.80x | n/a | -21.6% | n/a | n/a | n/a |
| Ocugen, Inc. OCGN | 275.9M | n/m | n/m | n/a | -20.7% | n/m | n/m | n/a |
| Nautilus Biotechnology, Inc. NAUT | 274.9M | n/m | 1.74x | n/a | -19.1% | n/a | n/a | n/a |
| Century Therapeutics, Inc. IPSC | 271.6M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Palisade Bio, Inc. PALI | 268.4M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Sagimet Biosciences Inc. SGMT | 266.2M | n/m | 2.37x | n/a | n/a | n/a | 0.0007 | n/a |
| Abeona Therapeutics Inc. ABEO | 265.3M | 3.47x | 1.93x | n/a | -27.4% | -84.5% | 0.16 | n/a |
| EyePoint Pharmaceuticals, Inc. EYPT | 263.3M | n/m | 0.86x | n/a | -92.5% | n/a | 0.07 | n/a |
| Cabaletta Bio, Inc. CABA | 262.8M | n/m | 2.35x | n/a | -50.4% | n/a | n/a | n/a |
| X4 Pharmaceuticals, Inc. XFOR | 261.7M | n/m | n/a | n/a | n/a | n/a | 0.41 | n/a |
| Quantum-Si incorporated QSI | 260.6M | n/m | 1.18x | n/a | -37.5% | n/a | n/a | n/a |
| Rocket Pharmaceuticals, Inc. RCKT | 259.1M | n/m | 0.95x | n/a | -72.6% | -103.2% | 0.09 | n/a |
| Vanda Pharmaceuticals Inc. VNDA | 256.4M | n/m | 0.76x | n/a | -44.2% | n/a | n/a | n/a |
| Inhibikase Therapeutics, Inc. IKT | 255.4M | n/m | 1.04x | n/a | -15.4% | n/a | n/a | n/a |
| Bicycle Therapeutics plc BCYC | 252.0M | n/m | 0.41x | n/a | -101.0% | n/a | n/a | n/a |
| Lineage Cell Therapeutics, Inc. LCTX | 250.5M | n/m | 5.12x | n/a | -8.5% | -547.2% | 0.05 | n/a |
| AC Immune S.A. ACIU | 249.3M | n/m | 4.60x | n/a | -34.0% | n/a | n/a | n/a |
| Galectin Therapeutics Inc. GALT | 244.3M | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| Amarin Corporation plc AMRN | 239.3M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| BridgeBio Oncology Therapeutics Inc. BBOT | 236.5M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| SAB Biotherapeutics, Inc. SABS | 235.7M | n/m | 1.56x | n/a | -19.4% | n/a | n/a | n/a |
| Immuneering Corporation IMRX | 235.5M | n/m | 0.73x | n/a | -28.4% | n/a | 0.02 | n/a |
| Q32 Bio Inc. QTTB | 231.3M | n/a | n/a | n/a | n/a | 186.5% | 0.37 | n/a |
| Eupraxia Pharmaceuticals Inc. EPRX | 226.7M | n/m | 2.76x | n/a | -12.9% | n/a | n/a | n/a |
| Lexeo Therapeutics, Inc. Common Stock LXEO | 226.6M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Greenwich LifeSciences, Inc. GLSI | 224.9M | n/m | 587.05x | n/a | n/a | n/a | n/a | n/a |
| Sol-Gel Technologies Ltd. SLGL | 224.9M | n/m | 9.86x | n/a | 0.1% | n/a | n/a | n/a |
| Fate Therapeutics, Inc. FATE | 224.4M | n/m | 1.10x | n/a | -49.0% | n/a | n/a | n/a |
| Keros Therapeutics, Inc. KROS | 220.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| DBV Technologies S.A. DBVT | 217.9M | n/m | n/a | n/a | n/a | n/m | 0.04 | n/a |
| Protalix BioTherapeutics, Inc. PLX | 217.5M | n/m | 4.40x | n/a | -6.4% | n/a | n/a | n/a |
| CAMP4 Therapeutics Corporation CAMP | 216.5M | n/m | n/a | n/a | n/a | n/m | 0.04 | n/a |
| MacroGenics, Inc. MGNX | 214.7M | n/m | 3.83x | n/a | -39.0% | n/a | n/a | n/a |
| Alector, Inc. ALEC | 213.3M | n/m | 6.42x | n/a | -93.6% | n/a | 1.19 | n/a |
| InflaRx N.V. IFRX | 212.2M | n/m | 26.39x | n/a | -18.7% | n/a | n/a | n/a |
| Larimar Therapeutics, Inc. LRMR | 206.7M | n/m | 2.65x | n/a | -54.8% | n/m | 0.05 | n/a |
| Niagen Bioscience Inc NAGE | 204.1M | 11.73x | 2.88x | n/a | n/a | n/a | n/a | n/a |
| BioAge Labs, Inc. BIOA | 201.4M | n/m | 0.71x | n/a | -42.8% | -104.6% | 0.02 | n/a |
| Lyell Immunopharma, Inc. LYEL | 200.7M | n/m | 0.56x | n/a | -107.7% | n/a | n/a | n/a |
| ProQR Therapeutics N.V. PRQR | 200.2M | n/m | 3.62x | n/a | -30.1% | n/m | 0.32 | n/a |
| Cartesian Therapeutics, Inc. RNAC | 199.1M | n/m | n/m | n/a | -46.5% | n/m | n/m | n/a |
| Invivyd, Inc. IVVD | 197.1M | n/m | n/a | n/a | n/a | n/a | 0.01 | n/a |
| Compugen Ltd. CGEN | 197.0M | 5.57x | 1.92x | 3.49x | 15.9% | 207.2% | 0.03 | n/a |
| Akebia Therapeutics, Inc. AKBA | 192.7M | n/m | 5.48x | 1.95x | 37.9% | n/m | 1.59 | n/a |
| Prelude Therapeutics Incorporated PRLD | 192.2M | n/m | 3.72x | n/a | -22.1% | n/a | 0.26 | n/a |
| ADC Therapeutics S.A. ADCT | 190.2M | n/m | n/m | n/a | -74.7% | n/a | n/m | n/a |
| Sutro Biopharma, Inc. STRO | 190.0M | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| Surrozen, Inc. SRZN | 187.5M | n/m | n/m | n/a | -16.2% | n/a | n/m | n/a |
| Entrada Therapeutics, Inc. TRDA | 186.1M | n/m | 0.65x | n/a | -65.5% | n/a | 0.17 | n/a |
| Upstream Bio, Inc. UPB | 184.6M | n/m | 0.53x | n/a | -73.5% | n/a | 0.004 | n/a |
| Eledon Pharmaceuticals, Inc. ELDN | 184.5M | n/m | 2.29x | n/a | n/a | n/a | 0.01 | n/a |
| PepGen Inc. PEPG | 175.0M | n/m | n/a | n/a | n/a | n/a | 0.12 | n/a |
| Oramed Pharmaceuticals Inc. ORMP | 173.9M | 2.73x | 0.89x | n/a | -5.2% | n/a | n/a | n/a |
| Whitehawk Therapeutics Inc WHWK | 173.3M | n/m | 1.38x | n/a | -52.1% | -115.9% | n/a | n/a |
| Precision BioSciences, Inc. DTIL | 170.3M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Coherus Oncology, Inc. CHRS | 165.3M | 0.75x | 2.05x | n/a | n/m | n/a | n/a | n/a |
| Inventiva S.A. IVA | 161.7M | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| Compass Therapeutics, Inc. CMPX | 161.5M | n/m | 0.72x | n/a | -34.8% | n/a | 0.05 | n/a |
| Zentalis Pharmaceuticals, Inc. ZNTL | 159.5M | n/m | 0.74x | n/a | -77.8% | n/a | n/a | n/a |
| Innate Pharma S.A. IPHA | 157.9M | n/m | n/m | n/a | -37.6% | n/a | n/m | n/a |
| MediWound Ltd. MDWD | 157.6M | n/m | 3.61x | n/a | -13.7% | n/a | n/a | n/a |
| Jyong Biotech Ltd. Ordinary Shares MENS | 150.5M | n/m | n/m | n/a | n/a | n/m | n/m | n/a |
| Tharimmune, Inc. CNTN | 149.0M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Codexis, Inc. CDXS | 148.9M | n/m | 2.35x | n/a | -20.1% | n/a | 1.45 | n/a |
| NovaBridge Biosciences NBP | 148.7M | n/m | 0.64x | n/a | -13.9% | n/a | 0.01 | n/a |
| Molecular Partners AG MOLN | 143.5M | n/m | 1.48x | n/a | -43.8% | n/a | n/a | n/a |
| Protara Therapeutics, Inc. TARA | 141.8M | n/m | 0.52x | n/a | -54.9% | n/a | 0.02 | n/a |
| ALX Oncology Holdings Inc. ALXO | 138.3M | n/m | n/a | n/a | n/a | -426.7% | 0.57 | n/a |
| Nkarta, Inc. NKTX | 138.2M | n/m | 0.46x | n/a | -63.0% | n/a | 0.24 | n/a |
| Anavex Life Sciences Corp. AVXL | 137.2M | n/m | 1.33x | n/a | n/a | n/a | n/a | n/a |
| Korro Bio, Inc. KRRO | 137.1M | n/m | n/a | n/a | n/a | n/a | 0.85 | n/a |
| AN2 Therapeutics, Inc. ANTX | 135.9M | n/m | 2.05x | n/a | n/a | n/a | n/a | n/a |
| Cue Biopharma, Inc. CUE | 135.6M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Voyager Therapeutics, Inc. VYGR | 126.9M | n/m | 0.62x | n/a | -111.7% | n/a | n/a | n/a |
| Humacyte, Inc. HUMA | 122.1M | n/m | n/a | n/a | n/a | -619.4% | 20.86 | n/a |
| Outlook Therapeutics, Inc. OTLK | 121.7M | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| Acumen Pharmaceuticals, Inc. ABOS | 120.8M | n/m | 1.44x | n/a | -114.3% | n/a | 0.44 | n/a |
| Spruce Biosciences, Inc. SPRB | 119.2M | n/m | n/a | n/a | n/a | n/m | 0.02 | n/a |
| NRx Pharmaceuticals, Inc. NRXP | 117.3M | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| TuHURA Biosciences, Inc. HURA | 116.6M | n/m | 4.19x | n/a | -31.6% | n/a | n/a | n/a |
| Minerva Neurosciences, Inc. NERV | 115.5M | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| Armata Pharmaceuticals, Inc. ARMP | 114.9M | n/m | n/m | n/a | -23.5% | n/a | n/m | n/a |
| enGene Holdings Inc. ENGN | 114.6M | n/a | 0.52x | n/a | -115.2% | n/a | n/a | n/a |
| Pyxis Oncology, Inc. PYXS | 114.0M | n/m | 2.09x | n/a | -56.8% | n/a | 0.35 | n/a |
| Seer, Inc. SEER | 113.0M | n/m | 0.44x | n/a | -40.9% | n/a | n/a | n/a |
| Foghorn Therapeutics Inc. FHTX | 112.2M | n/m | n/m | n/a | -72.4% | n/m | n/m | n/a |
| Genelux Corporation GNLX | 112.2M | n/m | 7.99x | n/a | -28.6% | n/a | n/a | n/a |
| LENZ Therapeutics, Inc. LENZ | 112.2M | n/m | 0.36x | n/a | -68.0% | n/a | 0.003 | n/a |
| Cellectis S.A. CLLS | 111.3M | n/m | 1.47x | n/a | -37.5% | n/a | n/a | n/a |
| Tonix Pharmaceuticals Holding Corp. TNXP | 110.1M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| vTv Therapeutics Inc. VTVT | 109.1M | n/m | 1.69x | n/a | n/a | n/a | n/a | n/a |
| Coya Therapeutics, Inc. COYA | 101.8M | n/m | 1.69x | n/a | n/a | n/a | n/a | n/a |
| Insight Molecular Diagnostics Inc. IMDX | 100.1M | n/m | n/m | n/a | -27.2% | n/a | n/m | n/a |
| Black Diamond Therapeutics, Inc. BDTX | 99.7M | 4.46x | 0.89x | 7.82x | n/a | n/a | 0.17 | n/a |
| PolyPid Ltd. PYPD | 99.5M | n/m | 9.07x | n/a | -28.2% | n/a | 0.25 | n/a |
| Milestone Pharmaceuticals Inc. MIST | 98.9M | n/m | 2.37x | n/a | -49.9% | n/a | 1.40 | n/a |
| Cibus, Inc. CBUS | 98.6M | n/m | n/a | n/a | n/a | n/a | 1.51 | n/a |
| Unicycive Therapeutics, Inc. UNCY | 98.3M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| NeurAxis, Inc. NRXS | 97.2M | n/m | 20.68x | n/a | -9.2% | n/m | 0.12 | n/a |
| Immunic, Inc. IMUX | 96.9M | n/m | n/m | n/a | n/a | n/m | n/m | n/a |
| Atara Biotherapeutics, Inc. ATRA | 96.9M | 3.70x | n/m | n/a | -41.5% | n/a | n/m | n/a |
| Anixa Biosciences, Inc. ANIX | 96.6M | n/m | 6.37x | n/a | n/a | n/a | 0.01 | n/a |
| ImmuCell Corporation ICCC | 95.9M | n/m | 3.52x | 63.48x | 1.3% | n/a | 0.49 | n/a |
| Tenaya Therapeutics, Inc. TNYA | 91.6M | n/m | 0.51x | n/a | -110.3% | -278.2% | 0.09 | n/a |
| Adagene Inc. ADAG | 90.4M | n/m | 2.56x | n/a | -17.4% | n/m | 0.18 | n/a |
| Rallybio Corporation RLYB | 89.1M | n/m | 1.63x | n/a | n/a | -123.6% | 0.003 | n/a |
| OnKure Therapeutics, Inc. OKUR | 86.3M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Corbus Pharmaceuticals Holdings, Inc. CRBP | 83.8M | n/m | 0.39x | n/a | -111.8% | n/a | 0.01 | n/a |
| Equillium, Inc. EQ | 83.7M | n/m | 2.65x | n/a | -30.1% | n/m | 0.03 | n/a |
| Neumora Therapeutics, Inc. Common Stock NMRA | 80.2M | n/m | 0.67x | n/a | n/a | n/a | 1.11 | n/a |
| ProMIS Neurosciences, Inc. PMN | 78.0M | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| Pelthos Therapeutics Inc. PTHS | 77.6M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Telomir Pharmaceuticals, Inc. Common Stock TELO | 77.3M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Nutriband Inc. NTRB | 76.2M | n/m | 11.41x | n/a | -6.7% | n/a | 0.04 | n/a |
| Cardiff Oncology, Inc. CRDF | 75.5M | n/m | 1.43x | n/a | -58.5% | -170.3% | 0.02 | n/a |
| Acrivon Therapeutics, Inc. Common Stock ACRV | 75.4M | n/m | 0.60x | n/a | -96.4% | -114.1% | 0.02 | n/a |
| OKYO Pharma Limited OKYO | 75.0M | n/m | n/m | n/a | -2.4% | n/a | n/m | n/a |
| PDS Biotechnology Corporation PDSB | 72.8M | n/m | 6.52x | n/a | -46.0% | n/m | 1.83 | n/a |
| Inovio Pharmaceuticals, Inc. INO | 71.9M | n/m | 2.02x | n/a | -182.3% | n/a | n/a | n/a |
| Heron Therapeutics, Inc. HRTX | 71.5M | n/m | 4.38x | n/a | -44.5% | n/a | n/a | n/a |
| MediciNova, Inc. MNOV | 71.4M | n/m | 1.71x | n/a | -13.8% | n/a | n/a | n/a |
| MAIA Biotechnology, Inc. MAIA | 70.4M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Cognition Therapeutics, Inc. CGTX | 69.7M | n/m | 1.56x | n/a | n/a | n/a | n/a | n/a |
| PMV Pharmaceuticals, Inc. PMVP | 68.8M | n/m | 0.65x | n/a | -108.6% | -124.1% | 0.01 | n/a |
| Tiziana Life Sciences Ltd TLSA | 66.8M | n/m | 16.97x | n/a | -2.3% | n/a | n/a | n/a |
| Champions Oncology, Inc. CSBR | 66.7M | n/m | 16.82x | n/a | -7.6% | n/a | 1.17 | n/a |
| OS Therapies Incorporated OSTX | 66.0M | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| MindWalk Holdings Corp. HYFT | 66.0M | n/m | 3.96x | n/a | -7.7% | n/a | n/a | n/a |
| XBiotech Inc. XBIT | 65.9M | n/m | 0.47x | n/a | -61.1% | n/a | n/a | n/a |
| Spero Therapeutics, Inc. SPRO | 65.8M | 7.53x | 1.13x | n/a | n/a | n/a | n/a | n/a |
| Verrica Pharmaceuticals Inc. VRCA | 64.9M | n/m | n/a | n/a | n/a | n/m | 0.07 | n/a |
| Cingulate Inc. CING | 63.8M | n/m | n/a | n/a | n/a | n/a | 3.50 | n/a |
| Fortress Biotech, Inc. FBIO | 63.7M | n/m | 1.28x | n/a | n/a | n/a | n/a | n/a |
| Apollomics, Inc. APLM | 61.2M | n/m | 12.59x | n/a | -47.0% | n/m | 0.20 | n/a |
| Biomea Fusion, Inc. BMEA | 60.5M | n/m | 1.48x | n/a | n/a | n/a | n/a | n/a |
| Pliant Therapeutics, Inc. PLRX | 60.2M | n/m | 0.33x | n/a | n/m | n/a | n/a | n/a |
| Xilio Therapeutics, Inc. XLO | 59.4M | n/m | 2.14x | n/a | -7.3% | n/a | n/a | n/a |
| Connect Biopharma Holdings Limited CNTB | 57.1M | n/m | 1.20x | n/a | -102.4% | n/a | 0.02 | n/a |
| Gain Therapeutics, Inc. GANX | 56.7M | n/m | 2.36x | n/a | n/a | n/m | 0.04 | n/a |
| Fractyl Health, Inc. Common Stock GUTS | 55.2M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Gossamer Bio, Inc. GOSS | 54.3M | n/m | n/m | n/a | n/m | n/a | n/m | n/a |
| RenovoRx, Inc. RNXT | 53.7M | n/m | 7.75x | n/a | -26.1% | n/a | n/a | n/a |
| Boundless Bio, Inc. BOLD | 53.5M | n/m | 0.53x | n/a | -89.8% | n/a | n/a | n/a |
| MiNK Therapeutics, Inc. INKT | 50.7M | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| iBio, Inc. IBIO | 50.3M | n/m | n/a | n/a | n/a | -111.5% | 0.03 | n/a |
| Caribou Biosciences, Inc. CRBU | 49.8M | n/m | 0.36x | n/a | n/m | n/a | n/a | n/a |
| Mereo BioPharma Group plc MREO | 49.4M | n/m | n/a | n/a | n/a | n/a | 0.005 | n/a |
| Werewolf Therapeutics, Inc. HOWL | 48.5M | n/m | 1.88x | n/a | -129.2% | n/a | n/a | n/a |
| Adicet Bio, Inc. ACET | 48.1M | n/m | 0.22x | n/a | n/m | -90.4% | 0.09 | n/a |
| Kalaris Therapeutics Inc KLRS | 47.8M | n/m | 0.42x | n/a | -115.3% | n/a | n/a | n/a |
| Eloxx Pharmaceuticals, Inc. ELOX | 47.1M | n/m | n/m | n/a | n/a | n/m | n/m | n/a |
| Clene Inc. CLNN | 47.0M | n/m | n/m | n/a | -57.0% | n/a | n/m | n/a |
| Alterity Therapeutics Limited ATHE | 46.1M | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| INmune Bio, Inc. INMB | 45.8M | n/m | 1.74x | n/a | -57.8% | n/m | 0.04 | n/a |
| ImageneBio Inc IMA | 45.8M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Annovis Bio, Inc. ANVS | 44.8M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Aldeyra Therapeutics, Inc. ALDX | 44.5M | n/m | 1.00x | n/a | n/a | n/m | 0.35 | n/a |
| Rani Therapeutics Holdings, Inc. RANI | 44.4M | n/m | 1.35x | n/a | -42.3% | n/a | 0.13 | n/a |
| Celularity Inc. CELU | 43.2M | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| Dogwood Therapeutics, Inc. DWTX | 42.5M | n/m | n/a | n/a | n/a | n/a | 0.002 | n/a |
| Veru Inc. VERU | 41.6M | n/m | 1.95x | n/a | -84.1% | n/a | n/a | n/a |
| Instil Bio, Inc. TIL | 41.6M | n/m | 0.36x | n/a | n/a | n/a | n/a | n/a |
| Tenax Therapeutics, Inc. TENX | 40.0M | n/m | 0.61x | n/a | n/a | n/m | n/a | n/a |
| eXoZymes, Inc. EXOZ | 37.1M | n/m | 9.87x | n/a | -19.9% | -600.0% | 0.37 | n/a |
| Filana Therapeutics, Inc. FLNA | 36.8M | n/m | 0.49x | n/a | -89.4% | n/a | n/a | n/a |
| Lite Strategy, Inc. LITS | 36.3M | n/m | 0.99x | n/a | n/a | -185.4% | n/a | n/a |
| NanoViricides, Inc. NNVC | 35.0M | n/m | 3.19x | n/a | -28.1% | n/a | n/a | n/a |
| Elutia Inc. ELUT | 34.9M | 0.61x | 1.31x | n/a | -128.8% | n/a | n/a | n/a |
| CervoMed Inc. CRVO | 34.0M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Elicio Therapeutics, Inc. ELTX | 33.9M | n/m | 16.66x | n/a | -135.6% | n/m | 8.87 | n/a |
| Aligos Therapeutics, Inc. ALGS | 33.7M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Actinium Pharmaceuticals, Inc. ATNM | 33.3M | n/m | 4.22x | n/a | -74.7% | n/m | 0.22 | n/a |
| BriaCell Therapeutics Corp. BCTX | 32.8M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Metagenomi, Inc. Common Stock MGX | 31.9M | n/m | 0.20x | n/a | n/m | -60.9% | 0.26 | n/a |
| GridAI Technologies Corp. GRDX | 31.8M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Grace Therapeutics, Inc. GRCE | 31.7M | n/m | 0.50x | n/a | n/a | -19.4% | n/a | n/a |
| NextCure, Inc. NXTC | 31.5M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| CEL-SCI Corporation CVM | 30.6M | n/m | n/a | n/a | n/m | n/a | 1.09 | n/a |
| Tevogen Bio Holdings Inc. TVGN | 29.5M | n/m | n/m | n/a | -52.7% | n/a | n/m | n/a |
| Nasus Pharma Ltd. NSRX | 27.3M | n/m | 9.85x | n/a | -18.1% | n/a | n/a | n/a |
| TAO Synergies Inc. TAOX | 27.1M | n/m | n/a | n/a | n/a | -58.2% | n/a | n/a |
| Impact BioMedical Inc. IBO | 26.9M | n/m | n/a | n/a | n/a | -28.6% | n/a | n/a |
| Serina Therapeutics, Inc. SER | 26.9M | n/m | n/m | n/a | -98.8% | n/a | n/m | n/a |
| Atossa Therapeutics, Inc. ATOS | 26.4M | n/m | 0.58x | n/a | -130.5% | n/m | n/a | n/a |
| IGC Pharma, Inc. IGC | 26.3M | n/m | 3.07x | n/a | -25.2% | -120.8% | 0.04 | n/a |
| Edesa Biotech, Inc. EDSA | 25.7M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Seres Therapeutics, Inc. MCRB | 25.1M | 3.95x | 0.51x | n/a | 3.9% | n/a | n/a | n/a |
| ABVC BioPharma, Inc. ABVC | 24.9M | n/m | 1.69x | n/a | n/a | n/a | 0.24 | n/a |
| BeyondSpring Inc. BYSI | 23.9M | n/m | n/m | n/a | -82.8% | n/a | n/m | n/a |
| Immutep Limited IMMP | 23.6M | n/m | 0.24x | n/a | -181.7% | n/a | n/a | n/a |
| Estrella Immunopharma, Inc. ESLA | 23.3M | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| Context Therapeutics Inc. CNTX | 22.1M | n/m | 0.38x | n/a | -115.4% | n/m | 0.002 | n/a |
| LeonaBio, Inc. LONA | 20.9M | n/m | 0.81x | n/a | n/a | n/a | n/a | n/a |
| Akari Therapeutics, Plc AKTX | 20.3M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Cocrystal Pharma, Inc. COCP | 19.8M | n/m | n/a | n/a | n/a | n/a | 0.24 | n/a |
| aTyr Pharma, Inc. ATYR | 18.0M | n/m | 0.25x | n/a | n/m | -112.9% | 0.18 | n/a |
| Jasper Therapeutics, Inc. JSPR | 17.7M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Evaxion Biotech A/S EVAX | 17.7M | n/m | 1.04x | n/a | -37.5% | n/a | 0.44 | n/a |
| Dyadic International, Inc. DYAI | 16.8M | n/m | 11.10x | n/a | n/a | n/a | n/a | n/a |
| Marker Therapeutics, Inc. MRKR | 15.3M | n/m | 0.84x | n/a | n/a | n/a | n/a | n/a |
| TScan Therapeutics, Inc. TCRX | 15.2M | n/m | n/a | n/a | n/m | n/a | 0.76 | n/a |
| Tvardi Therapeutics, Inc. TVRD | 14.3M | n/m | n/a | n/a | n/a | n/a | 0.01 | n/a |
| BioCardia, Inc. BCDA | 14.2M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Lipocine Inc. LPCN | 13.8M | n/m | 0.66x | n/a | n/a | n/a | n/a | n/a |
| Pasithea Therapeutics Corp. KTTA | 13.7M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Vyome Holdings, Inc. HIND | 13.4M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Allarity Therapeutics, Inc. ALLR | 13.3M | n/m | 1.22x | n/a | -123.8% | n/m | 0.14 | n/a |
| Citius Pharmaceuticals, Inc. CTXR | 12.6M | n/m | n/a | n/a | n/a | n/a | 4.45 | n/a |
| Genenta Science S.p.A. GNTA | 12.2M | n/m | 0.50x | n/a | -63.1% | n/a | n/a | n/a |
| AEON Biopharma, Inc. AEON | 12.1M | n/m | n/m | n/a | n/m | n/a | n/m | n/a |
| Actuate Therapeutics Inc ACTU | 12.0M | n/m | 1.33x | n/a | n/a | n/a | n/a | n/a |
| Kazia Therapeutics Limited KZIA | 12.0M | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| IN8bio, Inc. INAB | 11.7M | n/m | n/a | n/a | n/m | n/a | 0.10 | n/a |
| Ensysce Biosciences, Inc. ENSC | 11.6M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Passage Bio, Inc. PASG | 11.6M | n/m | 0.61x | n/a | n/a | n/a | n/a | n/a |
| Palatin Technologies, Inc. PTN | 11.6M | n/m | n/a | n/a | n/a | n/m | 0.03 | n/a |
| Cellectar Biosciences, Inc. CLRB | 11.3M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Polyrizon Ltd. PLRZ | 11.2M | n/m | 0.53x | n/a | -40.4% | n/a | n/a | n/a |
| Daré Bioscience, Inc. DARE | 11.1M | n/m | 2.91x | n/a | -124.2% | n/a | n/a | n/a |
| Phio Pharmaceuticals Corp. PHIO | 10.8M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Tempest Therapeutics, Inc. TPST | 10.7M | n/m | n/a | n/a | n/m | n/a | 1.22 | n/a |
| Kiora Pharmaceuticals, Inc. KPRX | 10.7M | n/m | 0.61x | n/a | -101.8% | n/a | n/a | n/a |
| CytoMed Therapeutics Limited GDTC | 10.3M | n/m | 2.02x | n/a | -32.9% | n/a | 0.07 | n/a |
| BioLineRx Ltd. BLRX | 10.2M | n/m | 0.56x | n/a | -79.4% | n/a | n/a | n/a |
| Pluri Inc. PLUR | 10.1M | n/m | n/m | n/a | n/m | n/a | n/m | n/a |
| BioVie Inc. BIVI | 9.8M | n/m | 0.80x | n/a | n/a | n/a | 0.03 | n/a |
| Theriva Biologics, Inc. TOVX | 9.7M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Lisata Therapeutics, Inc. LSTA | 9.6M | n/m | 0.63x | n/a | -171.9% | n/m | n/a | n/a |
| Artelo Biosciences, Inc. ARTL | 9.6M | n/m | n/m | n/a | n/m | n/a | n/m | n/a |
| VistaGen Therapeutics, Inc. VTGN | 9.5M | n/m | 0.23x | n/a | n/a | n/a | 0.03 | n/a |
| GT Biopharma, Inc. GTBP | 9.3M | n/m | n/a | n/a | n/a | n/m | n/a | n/a |
| Intensity Therapeutics, Inc. INTS | 9.1M | n/m | n/a | n/a | n/a | n/a | 0.01 | n/a |
| MetaVia Inc. MTVA | 9.0M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Quince Therapeutics, Inc. QNCX | 9.0M | n/m | n/m | n/a | n/m | n/m | n/m | n/a |
| Jaguar Health, Inc. JAGX | 8.9M | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| SeaStar Medical Holding Corporation ICU | 8.7M | n/m | 0.61x | n/a | n/a | n/a | 0.05 | n/a |
| Lantern Pharma Inc. LTRN | 8.5M | n/m | 1.11x | n/a | n/m | n/a | 0.01 | n/a |
| Adial Pharmaceuticals, Inc. ADIL | 8.2M | n/m | n/a | n/a | n/a | n/m | n/a | n/a |
| Bolt Biotherapeutics, Inc. BOLT | 8.2M | n/m | 0.30x | n/a | n/m | n/a | n/a | n/a |
| Senti Biosciences, Inc. SNTI | 8.1M | n/m | 1.05x | n/a | n/m | n/a | n/a | n/a |
| Karyopharm Therapeutics Inc. KPTI | 8.0M | n/m | n/m | n/a | n/m | n/a | n/m | n/a |
| Quoin Pharmaceuticals, Ltd. QNRX | 8.0M | n/m | 0.61x | n/a | n/a | n/a | n/a | n/a |
| Chemomab Therapeutics Ltd. CMMB | 7.9M | n/m | 0.64x | n/a | -140.2% | n/m | n/a | n/a |
| Aprea Therapeutics, Inc. APRE | 7.8M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Soligenix, Inc. SNGX | 7.7M | n/m | n/a | n/a | n/m | n/m | 0.07 | n/a |
| CNS Pharmaceuticals, Inc. CNSP | 7.6M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Exicure, Inc. XCUR | 7.3M | n/m | 1.80x | n/a | -121.3% | n/a | 0.04 | n/a |
| InMed Pharmaceuticals Inc. INM | 7.3M | n/m | 5.15x | n/a | n/a | n/a | n/a | n/a |
| Ainos, Inc. AIMD | 7.1M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Skye Bioscience, Inc. SKYE | 7.0M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| AIM ImmunoTech Inc. AIM | 6.8M | n/m | n/m | n/a | n/a | n/m | n/m | n/a |
| FibroBiologics, Inc. Common Stock FBLG | 6.7M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Immuron Limited IMRN | 6.6M | n/m | 1.19x | n/a | n/a | n/a | n/a | n/a |
| Acurx Pharmaceuticals, Inc. ACXP | 6.5M | n/m | n/a | n/a | n/a | n/m | n/a | n/a |
| Alaunos Therapeutics, Inc. TCRT | 6.4M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Enveric Biosciences, Inc. ENVB | 6.2M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Traws Pharma, Inc. TRAW | 6.2M | n/a | n/m | n/a | n/m | n/m | n/m | n/a |
| NuCana plc NCNA | 6.2M | n/m | 0.19x | n/a | -160.0% | n/a | n/a | n/a |
| Alzamend Neuro, Inc. ALZN | 6.2M | n/m | 5.83x | n/a | n/a | n/a | n/a | n/a |
| NeuroSense Therapeutics Ltd. NRSN | 6.0M | n/m | n/m | n/a | -127.7% | n/a | n/m | n/a |
| Imunon, Inc. IMNN | 5.9M | n/m | n/a | n/a | n/m | n/m | 0.14 | n/a |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares CUPR | 5.2M | n/m | 1.33x | n/a | -137.1% | n/a | 0.10 | n/a |
| Cardio Diagnostics Holdings, Inc. CDIO | 5.2M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Pulmatrix, Inc. PULM | 5.2M | n/m | 1.35x | n/a | n/a | n/m | n/a | n/a |
| Lexaria Bioscience Corp. LEXX | 4.9M | n/m | n/a | n/a | n/m | n/a | 0.04 | n/a |
| Medicus Pharma Ltd. Common Stock MDCX | 4.9M | n/m | n/m | n/a | n/a | n/m | n/m | n/a |
| CollPlant Biotechnologies Ltd. CLGN | 4.8M | n/m | 0.78x | n/a | -198.0% | n/a | 0.47 | n/a |
| Processa Pharmaceuticals, Inc. PCSA | 4.8M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Xenetic Biosciences, Inc. XBIO | 4.7M | n/m | 0.46x | n/a | n/a | n/m | n/a | n/a |
| Longeveron Inc. LGVN | 4.6M | n/m | 0.80x | n/a | n/m | n/a | 0.15 | n/a |
| Jupiter Neurosciences, Inc. JUNS | 4.1M | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| PharmaCyte Biotech, Inc. PMCB | 3.8M | n/m | 0.09x | n/a | n/a | n/a | n/a | n/a |
| Enlivex Therapeutics Ltd. ENLV | 3.8M | n/a | n/a | n/a | n/m | -0.6% | 0.0002 | n/a |
| Lunai Bioworks Inc. LNAI | 3.7M | n/m | n/m | n/a | -190.7% | n/a | n/m | n/a |
| Addex Therapeutics Ltd ADXN | 3.7M | 0.44x | 0.32x | n/a | -174.6% | -43.2% | 0.004 | n/a |
| Aptevo Therapeutics Inc. APVO | 3.7M | n/m | n/a | n/a | n/a | n/a | 0.27 | n/a |
| KALA BIO, Inc. KALA | 3.7M | n/m | n/a | n/a | n/a | n/m | n/a | n/a |
| Dermata Therapeutics, Inc. DRMA | 3.7M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Ernexa Therapeutics Inc. ERNA | 3.5M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Cadrenal Therapeutics, Inc. Common Stock CVKD | 3.5M | n/m | n/a | n/a | n/m | n/m | n/a | n/a |
| Evogene Ltd. EVGN | 3.4M | n/m | n/m | n/a | n/m | n/a | n/m | n/a |
| CalciMedica, Inc. CALC | 3.4M | n/m | n/m | n/a | n/m | n/a | n/m | n/a |
| Clearmind Medicine Inc. CMND | 3.3M | n/m | 2.73x | n/a | n/a | n/a | n/a | n/a |
| 60 Degrees Pharmaceuticals, Inc. SXTP | 3.2M | n/m | n/a | n/a | n/m | -368.4% | 0.04 | n/a |
| GRI Bio, Inc. GRI | 3.1M | n/m | n/a | n/a | n/m | n/m | 0.01 | n/a |
| Revelation Biosciences, Inc. REVB | 3.0M | n/m | n/a | n/a | n/a | n/m | 0.08 | n/a |
| VivoSim Labs, Inc. VIVS | 2.8M | n/m | n/m | n/a | n/m | n/a | n/m | n/a |
| GeoVax Labs, Inc. GOVX | 2.6M | n/m | n/a | n/a | n/m | n/a | 0.22 | n/a |
| Mustang Bio, Inc. MBIO | 2.6M | n/m | 0.20x | n/a | n/a | n/a | n/a | n/a |
| XORTX Therapeutics Inc. XRTX | 2.6M | n/m | 0.22x | n/a | n/a | n/a | n/a | n/a |
| PMGC Holdings Inc. ELAB | 2.5M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Can-Fite BioPharma Ltd. CANF | 2.4M | n/m | 0.43x | n/a | n/m | n/a | n/a | n/a |
| Malachite Innovations, Inc. VBIO | 2.4M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Kairos Pharma, Ltd. KAPA | 2.3M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Calidi Biotherapeutics, Inc. CLDI | 2.2M | n/m | 0.60x | n/a | n/m | n/a | 0.71 | n/a |
| Virax Biolabs Group Limited VRAX | 2.2M | n/m | 0.38x | n/a | n/m | n/a | n/a | n/a |
| Creative Medical Technology Holdings, Inc. CELZ | 2.1M | n/m | 0.26x | n/a | n/a | n/a | n/a | n/a |
| BioRestorative Therapies, Inc. BRTX | 2.0M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Moleculin Biotech, Inc. MBRX | 2.0M | n/m | n/a | n/a | n/m | -387.0% | 0.02 | n/a |
| Oragenics, Inc. OGEN | 2.0M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Onconetix, Inc. ONCO | 2.0M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| TransCode Therapeutics, Inc. RNAZ | 1.9M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| XTL Biopharmaceuticals Ltd. XTLB | 1.8M | n/m | 0.33x | n/a | -92.5% | n/a | n/a | n/a |
| Radiopharm Theranostics Limited RADX | 1.4M | n/m | 0.03x | n/a | n/a | n/a | n/a | n/a |
| Moolec Science S.A. MLEC | 1.4M | n/m | 0.20x | n/a | n/m | n/a | n/a | n/a |
| Silo Pharma, Inc. SILO | 1.4M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| NewcelX Ltd. NCEL | 1.3M | n/m | 0.18x | n/a | n/m | n/a | n/a | n/a |
| Genprex, Inc. GNPX | 1.2M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| SciSparc Ltd. SPRC | 1.1M | n/m | 0.14x | n/a | n/a | n/a | n/a | n/a |
| Matinas BioPharma Holdings, Inc. MTNB | 1.0M | n/m | n/a | n/a | n/a | n/a | 0.28 | n/a |
| Aspire Biopharma Holdings, Inc. ASBP | 996.8K | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| Curis, Inc. CRIS | 990.6K | n/m | n/a | n/a | n/a | n/a | 0.30 | n/a |
| Propanc Biopharma, Inc. PPCB | 778.1K | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Azitra, Inc. AZTR | 768.0K | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Decoy Therapeutics Inc. DCOY | 654.3K | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Scinai Immunotherapeutics Ltd. SCNI | 466.0K | n/m | 0.06x | n/a | n/m | n/a | n/a | n/a |
| HCW Biologics Inc. HCWB | 427.6K | n/m | 0.15x | n/a | n/m | -172.7% | 2.46 | n/a |
| Biodexa Pharmaceuticals Plc BDRX | 321.9K | n/m | 0.02x | n/a | n/m | n/a | n/a | n/a |
| CDT Equity Inc. CDT | 235.0K | n/m | n/m | n/a | n/a | n/a | n/m | n/a |
| Purple Biotech Ltd. PPBT | 169.8K | n/m | 0.02x | n/a | n/m | n/a | n/a | n/a |
| Psyence Biomedical Ltd. PBM | 82.2K | 0.08x | 0.01x | n/a | n/m | n/a | n/a | n/a |
| Silexion Therapeutics Ltd. SLXN | 79.2K | n/a | n/a | n/a | n/m | n/a | n/a | n/a |
Largest published market value first. No ratio orders this list, and a company whose market value is not published is listed last.
Prices as of 2026-10-15. Ratios recomputed from the filings 2026-10-15. Every ratio passes the same applicability gate as the screener and the research page, with the latest filed fiscal year's statements. A list is not a recommendation: see the limits of what this tool can tell you.